- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Available formulations
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Dosages
| Haemofiltration with normal potassium levels |
|---|
|
| Haemofiltration with hyperkalaemia |
|---|
|
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Renal impaiment in children > 3 months
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects
No information is present at this moment.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications in children
Duosol: Hypokalaemia, metabolic alkalosis.
Acute renal failure with a pronounced hyperkatabolic status, if uraemic symptoms can no longer be corrected by haemofiltration; insufficient access to the blood hole; in cases of increased risk of bleeding as a result of systemic anticoagulation.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions
No information available on specific warnings and precautions in children.
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
| BLOOD AND RELATED PRODUCTS | ||
|---|---|---|
| B05AA01 | ||
| B05AA06 | ||
| I.V. SOLUTIONS | ||
|---|---|---|
| B05BB01 | ||
| B05BC01 | ||
| B05BB01 | ||
| B05BB03 | ||
| IRRIGATING SOLUTIONS | ||
|---|---|---|
| B05CX03 | ||
| B05CB10 | ||
| B05CB01 | ||
| I.V. SOLUTION ADDITIVES | ||
|---|---|---|
| B05XA07 | ||
| B05XA19 | ||
| B05XC | ||
| B05XA14 | ||
| B05XB01 | ||
| B05XA31 | ||
| B05XA06 | ||
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
References
- B. Braun Avitum AG, SmPC Duosol met kalium (RVG 28528) 26-02-2015, www.cbg-meb.nl
- Gambro Lundia AB, SmPC Hemosol (RVG 23960) 21-09-2017, www.cbg-meb.nl
- Gambro Lundia AB, SmPC Phoxilium (RVG 101928) 21-09-2017, www.geneesmiddeleninformatiebank.nl
- Gambro Lundia AB, SmPC Prismasol (RVG 28877) 29-03-2018, www.geneesmiddeleninformatiebank.nl
A second drug has not been selected yet.
Press ‘drugs’ followed with and select second drug from list to add the second drug to the comparison.
Changes
Changes
